Mendoza-Sánchez F, Haro-Haro FJ, Sandoval-Alvarado J, Zepeda-González A, Herrera-Rodríguez R, Bassols-Ricardez A

Language: Spanish
References: 24
Page: 281-285
PDF size: 109.41 Kb.

ABSTRACT

Background: We undertook this study to describe the results of hepatic orthotopic transplant. Patient characteristics, implants, and patient evolution after transplant were studied. The study was conducted at a third-level medical facility in Mexico.
Methods: The files of 49 patients who had a liver transplant were reviewed from July 17, 1999 through November 30, 2006. We also analyzed pretransplant status and status of the hepatic implant at the time of the transplant. Finally, patient evolution was reported postoperatively.
Results: Fifty transplants were carried out in 49 patients (one man was retransplanted and one women had a liver and kidney transplant). There were 35 women (71.43 %) and 14 men (28.57 %). Ages of the patients were between 2 and 61 years (average 40.4 years). The most frequent causes resulting in transplants were cirrhosis caused by hepatitis C virus (HCV) and autoimmune cirrhosis: 28 cases (56 %) and 7 cases (14 %), respectively. Four patients (8 %) died from surgery-related complications and 11 patients died (22 %) from nonsurgical complications. Patient survival according to Child-Pugh is as follows: Child-Pugh A: 3/4 patients (75 %), Child-Pugh B: 17/24 patients (70 %), Child-Pugh C: 15/22 patients (68 %). Preoperative survival was 35 patients (70 %), 1-year survival was 32 patients (64) and 5-year survival was 29 patients (58 %).
Conclusions: Survival rates of our patients are acceptable even though the majority of those transplanted had severe hepatic insufficiency and others had diabetes and portal thrombosis.

REFERENCES

1. 1. Moore FD, Brownell WW, Demissiance HV, et al. Experimental whole-organ transplantation of the liver and the spleen. Ann Surg 1960;152:374-386.

2. 2. Starzl TE, Kaupp HA, Brock DR. Reconstructive problems in canine liver homotransplantations with special reference to postoperative role of hepatic venous flow. Surg Gynecol Obstet 1960;11:733-743.

3. 3. Starzl TE, Marchioro TL, Von Kaulla K, Herrman G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-676.

4. 4. Starzl TE, Groth CG, Brettschneider L, et al. Extended survival in 3 cases of orthotopic homotransplantations of the human liver. Surgery 1968;4:549-563.

5. 5. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology 1982;2:614-636.

6. 6. Iwatsuki S, Starzl TE, Todo S, et al. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 1988;20:498-504.

7. 7. National Institutes of Health. Consensus Development Conference statement liver transplantation, June 20-23, 1983. Hepatology 1984;4:107S-110S.

8. 8. Belle SH, Detre KM. Report from the Pitt-UNOS liver transplant registry. Transplant Proc 1983;25:1137-1142.

9. 9. Health Resources and Services Administration, Bureau of Health Resources Development. 1991 Report of Center-Specific Graft, Patient Survival Rates. Rockville, MD: US Department of Health and Human Services;1992.

10. 10. Szpakowski JL, Cox K, Nakazato P, Concepcion W, Levin B, Esquivel C. Liver transplantation: experience with 100 cases. West J Med 1991;155:494-499.

11. 11. Busutil RW, Shaked A, Millis JM, et al. One thousand liver transplants. Ann Surg 1994;219:490-499.

12. 12. Diliz H, Orozco H, Kershenobich D, Rodríguez LC, et al. Liver transplantation in Mexico. Report of the first successful case. Rev Gastroenterol Mex 1991;56:33-38.

13. 13. Secretaría de Salud. Informe de rendición de cuentas de la administración pública federal 2000-2006. Registro Nacional de Trasplantes. México: Centro Nacional de Trasplantes, Secretaría de Salud CENATRA; 2006.

14. 14. Jain A, Reyes J, Kasyad R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.

15. 15. Montefusco CM, Mollenkopf FP, Kamholz SL, Golsmith J, Veith FJ. Maintenance protocol for potential organ donors in multiple organ procurement. Hosp Physician 1984;20:9.

16. 16. Novitzky D, Cooper DKC, Reicha B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987;43:852-854.

17. 17. Cuevas-Mons V, Garrido A, Barrios C, et al. Prognostic value of preoperative Child-Pugh’s score in predicting postoperative survival in adult patients following liver transplantation. International Society for Perioperative Care in Liver Transplantation, University of Pittsburgh: September 1990.

18. 18. Baliga P, Merion RM, Turcotte JC, et al. Preoperative risk factors assessment in liver transplantation. Surgery 1992;112:704-711.

19. 19. Trail KC, McCashland TM, Larsen JL, et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transplant Surg 1996;2:276-283.

20. 20. Cherqui D, Duvoux C, Rahmouni A, Rotman N, Dhumeaux D, Julien M, Fagniez PL. Orthotopic liver transplantation in the presence of partial or total vein thrombosis: problems in diagnosis and management. World J Surg 1993;17:669-674.

21. 21. Figueras J, Sabaté A, Fabregat J, et al. Hemodynamics during the anhepatic phase in orthotopic liver transplantation with vena cava cava preservation: a comparative study. Transplant Proc 1993;25:2588-2589.

22. 22. Solares C, Maestre J, Pulgar S, et al. Hemodynamic changes during adult liver transplantation with partial vena cava camping. Transplant Proc 1993;25:1850.

23. 23. Howars TK, Klitmalm GBG, Cofer JB, et al. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990;49:103-107.

24. 24. Lerut J, Gordon RD, Iwatsuki S, et al. Biliary tract complication in human orthotopic liver transplantation. Transplantation 1987;43:47-51.